ASX - By Stock
|
BCT |
Re:
Ann: Trading Halt
|
|
petesherl
|
39 |
9.4K |
3 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
39
|
9.4K
|
3
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Change in substantial holding
|
|
petesherl
|
31 |
8.5K |
0 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
31
|
8.5K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
Two weeks until trial results
|
|
petesherl
|
59 |
17K |
0 |
05/11/18 |
05/11/18 |
ASX - By Stock
|
59
|
17K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
Two weeks until trial results
|
|
petesherl
|
59 |
17K |
4 |
04/11/18 |
04/11/18 |
ASX - By Stock
|
59
|
17K
|
4
|
|
ASX - By Stock
|
DLM |
Re:
for what purpose?
|
|
petesherl
|
30 |
9.6K |
2 |
03/11/18 |
03/11/18 |
ASX - By Stock
|
30
|
9.6K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
for what purpose?
|
|
petesherl
|
30 |
9.6K |
5 |
01/11/18 |
01/11/18 |
ASX - By Stock
|
30
|
9.6K
|
5
|
|
ASX - By Stock
|
DLM |
Re:
Two weeks until trial results
|
|
petesherl
|
59 |
17K |
4 |
29/10/18 |
29/10/18 |
ASX - By Stock
|
59
|
17K
|
4
|
|
ASX - By Stock
|
DLM |
Re:
SIC MUNDUS CREATUS EST
|
|
petesherl
|
3 |
849 |
3 |
26/10/18 |
26/10/18 |
ASX - By Stock
|
3
|
849
|
3
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Factor Therapeutics Appoints Transaction Advisor
|
|
petesherl
|
41 |
9.8K |
3 |
17/10/18 |
17/10/18 |
ASX - By Stock
|
41
|
9.8K
|
3
|
|
ASX - By Stock
|
DLM |
Re:
Resilience
|
|
petesherl
|
8 |
2.3K |
1 |
15/10/18 |
15/10/18 |
ASX - By Stock
|
8
|
2.3K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Silence of the Lamb
|
|
petesherl
|
4 |
1.1K |
0 |
12/10/18 |
12/10/18 |
ASX - By Stock
|
4
|
1.1K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
Silence of the Lamb
|
|
petesherl
|
4 |
1.1K |
1 |
12/10/18 |
12/10/18 |
ASX - By Stock
|
4
|
1.1K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Last patient completes treatment in VLU Ph 2 Clinical Trial
|
|
petesherl
|
20 |
9.3K |
2 |
05/10/18 |
05/10/18 |
ASX - By Stock
|
20
|
9.3K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Last patient completes treatment in VLU Ph 2 Clinical Trial
|
|
petesherl
|
20 |
9.3K |
1 |
04/10/18 |
04/10/18 |
ASX - By Stock
|
20
|
9.3K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Last patient completes treatment in VLU Ph 2 Clinical Trial
|
|
petesherl
|
20 |
9.3K |
4 |
04/10/18 |
04/10/18 |
ASX - By Stock
|
20
|
9.3K
|
4
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Shareholder Update Q3 2018
|
|
petesherl
|
57 |
17K |
3 |
02/10/18 |
02/10/18 |
ASX - By Stock
|
57
|
17K
|
3
|
|
ASX - By Stock
|
DLM |
Re:
book
|
|
petesherl
|
212 |
60K |
10 |
28/09/18 |
28/09/18 |
ASX - By Stock
|
212
|
60K
|
10
|
|
ASX - By Stock
|
DLM |
Re:
Are you ready for the next upcoming trading day?
|
|
petesherl
|
4 |
2.2K |
6 |
17/09/18 |
17/09/18 |
ASX - By Stock
|
4
|
2.2K
|
6
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Phase 2 Trial for Venous Leg Ulcers Nears Completion
|
|
petesherl
|
28 |
13K |
1 |
07/09/18 |
07/09/18 |
ASX - By Stock
|
28
|
13K
|
1
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Trading Halt
|
|
petesherl
|
30 |
10K |
1 |
06/09/18 |
06/09/18 |
ASX - By Stock
|
30
|
10K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO presentation to Broker Meets Biotech - Perth
|
|
petesherl
|
86 |
29K |
0 |
25/08/18 |
25/08/18 |
ASX - By Stock
|
86
|
29K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO presentation to Broker Meets Biotech - Perth
|
|
petesherl
|
86 |
29K |
2 |
24/08/18 |
24/08/18 |
ASX - By Stock
|
86
|
29K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO presentation to Broker Meets Biotech - Perth
|
|
petesherl
|
86 |
29K |
2 |
24/08/18 |
24/08/18 |
ASX - By Stock
|
86
|
29K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO presentation to Broker Meets Biotech - Perth
|
|
petesherl
|
86 |
29K |
2 |
24/08/18 |
24/08/18 |
ASX - By Stock
|
86
|
29K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
Value
|
|
petesherl
|
11 |
4.8K |
5 |
15/06/18 |
15/06/18 |
ASX - By Stock
|
11
|
4.8K
|
5
|
|
ASX - By Stock
|
DLM |
competition
|
|
petesherl
|
1 |
682 |
0 |
12/06/18 |
12/06/18 |
ASX - By Stock
|
1
|
682
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Acquisition of Amplia Therapeutics - Questions and Answers
|
|
petesherl
|
8 |
6.8K |
1 |
09/06/18 |
09/06/18 |
ASX - By Stock
|
8
|
6.8K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
run coming?
|
|
petesherl
|
93 |
28K |
3 |
24/05/18 |
24/05/18 |
ASX - By Stock
|
93
|
28K
|
3
|
|
ASX - By Stock
|
DLM |
Re:
Change in date of results
|
|
petesherl
|
7 |
2.1K |
3 |
06/04/18 |
06/04/18 |
ASX - By Stock
|
7
|
2.1K
|
3
|
|
ASX - By Stock
|
DLM |
Re:
Change in date of results
|
|
petesherl
|
7 |
2.1K |
1 |
06/04/18 |
06/04/18 |
ASX - By Stock
|
7
|
2.1K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Investor Presentation
|
|
petesherl
|
28 |
9.6K |
1 |
14/03/18 |
14/03/18 |
ASX - By Stock
|
28
|
9.6K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Trading Halt
|
|
petesherl
|
48 |
13K |
0 |
14/03/18 |
14/03/18 |
ASX - By Stock
|
48
|
13K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Trading Halt
|
|
petesherl
|
48 |
13K |
0 |
12/03/18 |
12/03/18 |
ASX - By Stock
|
48
|
13K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Trading Halt
|
|
petesherl
|
48 |
13K |
0 |
12/03/18 |
12/03/18 |
ASX - By Stock
|
48
|
13K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Clinical Trial Update
|
|
petesherl
|
24 |
6.7K |
1 |
12/03/18 |
12/03/18 |
ASX - By Stock
|
24
|
6.7K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Clinical Trial Update
|
|
petesherl
|
24 |
6.7K |
0 |
08/03/18 |
08/03/18 |
ASX - By Stock
|
24
|
6.7K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Clinical Trial Update
|
|
petesherl
|
24 |
6.7K |
2 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
24
|
6.7K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Appendix 4E Preliminary Final Report
|
|
petesherl
|
5 |
2.3K |
0 |
22/02/18 |
22/02/18 |
ASX - By Stock
|
5
|
2.3K
|
0
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Labcon begins production of Bluechiip-enabled consumables
|
|
petesherl
|
15 |
6.6K |
0 |
21/02/18 |
21/02/18 |
ASX - By Stock
|
15
|
6.6K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
Ann: One-hundredth patient recruited in VF001002 clinical trial
|
|
petesherl
|
4 |
2.0K |
3 |
12/02/18 |
12/02/18 |
ASX - By Stock
|
4
|
2.0K
|
3
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Clinical Trial Update
|
|
petesherl
|
9 |
3.2K |
0 |
18/01/18 |
18/01/18 |
ASX - By Stock
|
9
|
3.2K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix establishes Japanese subsidiary
|
|
petesherl
|
2 |
1.8K |
0 |
15/01/18 |
15/01/18 |
ASX - By Stock
|
2
|
1.8K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Shareholder Update
|
|
petesherl
|
4 |
1.7K |
2 |
15/01/18 |
15/01/18 |
ASX - By Stock
|
4
|
1.7K
|
2
|
|
ASX - By Stock
|
DLM |
delayed quarterly update = CR?
|
|
petesherl
|
1 |
497 |
0 |
10/01/18 |
10/01/18 |
ASX - By Stock
|
1
|
497
|
0
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Open Briefing interview with MD/CEO Andrew McLellan
|
|
petesherl
|
8 |
3.5K |
1 |
11/12/17 |
11/12/17 |
ASX - By Stock
|
8
|
3.5K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: 50% recruitment reached in VF00102 Clinical Trial
|
|
petesherl
|
7 |
2.3K |
0 |
29/11/17 |
29/11/17 |
ASX - By Stock
|
7
|
2.3K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
IPO - Telix Pharmaceuticals Limited
|
|
petesherl
|
65 |
38K |
1 |
02/11/17 |
02/11/17 |
ASX - By Stock
|
65
|
38K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Competition?
|
|
petesherl
|
4 |
1.5K |
2 |
08/10/17 |
08/10/17 |
ASX - By Stock
|
4
|
1.5K
|
2
|
|
ASX - By Stock
|
DLM |
Competition?
|
|
petesherl
|
4 |
1.5K |
3 |
08/10/17 |
08/10/17 |
ASX - By Stock
|
4
|
1.5K
|
3
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Shareholder communication - clinical trial update
|
|
petesherl
|
30 |
9.1K |
1 |
05/10/17 |
05/10/17 |
ASX - By Stock
|
30
|
9.1K
|
1
|
|